Press Releases
November 13, 2025 Press Release
Rapid Nexus Nanotech Wound Solutions, Inc., a California-based med-tech company focused on advanced wound care, today announced it has received FDA 510(k) clearance for its Hemastyl gel device—marking a historic milestone as the first company to directly target the underlying reason chronic wounds fail to heal….
September 23, 2025 Press Release
This patented breakthrough is the first and only technology to treat dying tissue and regenerate nerves — restoring circulation, reversing chronic wounds, and preventing amputations for patients who previously had no options…
Media Coverage & Latest Updates
Rapid Nexus hopes its regenerative wound-healing system can ease the burden of diabetic foot ulcers and amputations. Backed by early clinical data and $3.8m in seed funding, the start-up is targeting...
This patented breakthrough is the first and only technology to treat dying tissue and regenerate nerves — restoring circulation, reversing chronic wounds, and preventing amputations for patients who...
Dr. Margaret Kalmeta was handpicked by a panel of seasoned investors as the 1st-place winner at PitchForce, where she delivered a compelling 4-minute pitch on Rapid Nexus Nanotech Wound Solutions...
Dr. Margaret Kalmeta had the privilege of serving as Keynote Speaker at the Burn and Reconstructive Centers of America, presenting Rapid Nexus’s innovative Peri-wound treatment, Hemastyl™. The...
Dr. Margaret Kalmeta of Rapid Nexus Nanotech Wound Solutions, Inc. was recently featured on a podcast with Darwin Shurig at Shurig Solutions Inc., where she shared insights into the company’s...
Rapid Nexus Nanotech Wound Solutions, Inc. (hashtag#LSIEurope23 Innovator) received two additional patents in Q2, bringing their total number of patents to four U.S. issued patents and six...
At LSI, Dr. Kalmeta shares early results from Rapid Nexus’s regenerative wound care technology, highlighting that 17 amputations were prevented and 39 complex wounds were successfully closed by...
Dr. Margaret Kalmeta joins LSI Europe ’22 to discuss Rapid Nexus’s pioneering work in regenerative wound healing. In this interview, she shares insights into how the company’s proprietary nanotech...